跳至主要内容
临床试验/JPRN-UMIN000023117
JPRN-UMIN000023117已完成未知

Efficacy and safety of pregabalin for the treatment of neuropathic pain in patients undergoing hemodialysis - Efficacy and safety of pregabalin in patients undergoing hemodialysis

ihon University School of Medicine Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine0 个研究点目标入组 30 人开始时间: 2016年7月11日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) age < 20 years or > 85 years, (2) a history of severe heart failure, angina, myocardial infarction, or stroke within the past 6 months, (3) the presence of infectious disease, thyroid disease, malignant tumors, or treatment with steroids or immunosuppressants, (4) current hospitalization, (5) patients with a history of angioedema, and (6) patients with dementia who experience difficulty making a decision

研究者

发起方
ihon University School of Medicine Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine

相似试验